Mar. 12 at 11:03 PM
$AREB What is holding this down isn't very surprising. They do not qualify for the typical 180 day price deficiency cure period because of their reverse split history. The daily chart shows that this closed at
$0.9997 on February 10 and
$0.6095 on the 11th. Take your pick and count 30 business days for when they either trigger the reverse spilt that they filed February 18th or become another penny reverse splitting dilution scam in the OTC. Next week will be interesting and I don't mean in a good way. 😉
February 10th
https://www.sec.gov/ix?doc=/Archives/edgar/data/1648087/000149315226005972/form8-k.htm
...the Staff concluded that the Company is not eligible for the compliance period pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv) due to the fact that the Company effected four reverse stock splits since October of 2024,...
After the Company’s common stock is delisted, the Company intends to submit an application to trade on the OTCQB Venture Market (the “OTCQB”),...
